Eli Lilly enters venture capital arena

被引：0
|
作者：
Fletcher, L
机构：
来源：
NATURE BIOTECHNOLOGY | 2001年 / 19卷 / 11期
关键词：
D O I：
10.1038/nbt1101-997
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：997 / 998
页数：2
相关论文
共 50 条
  • [31] Eli Lilly announces restructuring, job cuts
    不详
    EJHP PRACTICE, 2009, 15 (05): : 14 - 14
  • [32] FDA approves Eli Lilly's baricitinib
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (07) : 460 - 460
  • [33] CEFACLOR (CECLOR - ELI-LILLY-AND-COMPANY)
    BERGMAN, HD
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1980, 14 (01): : 11 - 16
  • [34] WASTE DISPOSAL BY PULPING AT ELI LILLY AND COMPANY
    YOKE, WR
    MECHANICAL ENGINEERING, 1967, 89 (06) : 77 - &
  • [35] Eli Lilly and Company Insulins A Century of Innovation
    Malone, J. K.
    Anderson, J. H.
    Wolpert, H. A.
    Ilag, L. L.
    Frank, B. H.
    De Felippis, M. R.
    Paavola, C. D.
    Orr, A. L.
    Beals, J. M.
    PEDIATRIC ENDOCRINOLOGY REVIEWS PER, 2020, 17 : 138 - 160
  • [36] The History of Flow Chemistry at Eli Lilly and Company
    Johnson, Martin D.
    Braden, Timothy
    Calvin, Joel R.
    Brewer, Alison Campbell
    Cole, Kevin P.
    Frank, Scott
    Kerr, Mark
    Kjell, Doug
    Kopach, Michael E.
    Martinelli, Joseph R.
    May, Scott A.
    Rincon, Juan
    White, Timothy D.
    Yates, Matthew H.
    CHIMIA, 2023, 77 (05) : 319 - 326
  • [37] Eli Lilly - DNA patenting through the ages
    Burke, JF
    Thomas, SM
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1999, 9 (02) : 119 - 127
  • [38] HYBRITECH AGREES TO BE ACQUIRED BY ELI-LILLY
    不详
    CHEMICAL & ENGINEERING NEWS, 1985, 63 (38) : 5 - 6
  • [39] Eli Lilly plans multiple site closings
    不详
    BIOPHARM INTERNATIONAL, 2006, 19 (08) : 18 - 18
  • [40] Eli Lilly ordered to halt deceptive advertising
    不详
    CHEMICAL & ENGINEERING NEWS, 1999, 77 (30) : 15 - 15
12345